SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-073148
Filing Date
2011-08-05
Accepted
2011-08-05 06:01:14
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c20523e10vq.htm 10-Q 274995
2 EX-31.1 c20523exv31w1.htm EX-31.1 9119
3 EX-31.2 c20523exv31w2.htm EX-31.2 9108
4 EX-32.1 c20523exv32w1.htm EX-32.1 3811
5 EX-32.2 c20523exv32w2.htm EX-32.2 3861
  Complete submission text file 0000950123-11-073148.txt   931804

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT rgn-20110630.xml EX-101.INS 48738
7 EX-101 SCHEMA DOCUMENT rgn-20110630.xsd EX-101.SCH 7975
8 EX-101 CALCULATION LINKBASE DOCUMENT rgn-20110630_cal.xml EX-101.CAL 19233
9 EX-101 LABELS LINKBASE DOCUMENT rgn-20110630_lab.xml EX-101.LAB 75722
10 EX-101 PRESENTATION LINKBASE DOCUMENT rgn-20110630_pre.xml EX-101.PRE 47715
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 111012048
SIC: 2834 Pharmaceutical Preparations